Skip to main content

Table 3 Outcome of valve surgery within 30 days

From: A review of outcome following valve surgery for rheumatic heart disease in Australia

 

All

RHD-related

Non-RHD

P value

N = 17227

N = 1384

N = 15843

Initial admission

 Ventilation (hours) (median (IQR))

11.0(6.8 – 19.0)

12.0(7.0 – 19.0)

11.0(6.7 – 19.0)

0.009

 Intensive care unit (ICU) stay (hours) (median (IQR))

43.3(23.0 – 72.3)

42.0(23.0 – 70.8)

43.5(23.0 – 72.5)

0.350

 Post procedure length of stay (days) (median (IQR))

8.0(7.0 – 13.0)

8.0(7.0 – 13.0)

8.0(7.0 – 13.0)

0.648

 Re-operation for valve dysfunction (%, 95 % CI)

0.2(0.1 – 0.3)

0.4(0.1 – 0.8)

0.2(0.1 – 0.3)

0.152

 Re-operation not related to valve dysfunction (%, 95 % CI)

7.0(6.6 – 7.4)

7.3(6.0 – 8.8)

7.0(6.6 – 7.4)

0.652

Mortality

 All cause (%, 95 % CI)

4.2(3.8 – 4.5)

3.1(2.2 – 4.3)

4.3(3.9 – 4.6)

0.058

 Cardiac cause (%, 95 % CI)

1.5(1.3 – 1.8)

1.5(0.9 – 2.4)

1.5(1.3 – 1.8)

0.122

 Non-cardiac cause (%, 95 % CI)

2.7(2.4 – 2.9)

1.6(1.0 – 2.6)

2.8(2.5 – 3.0)

0.907

 Readmission (%, 95 % CI)

11.2(10.7 – 11.7)

13.8(12.0 – 15.7)

11.0(10.5 – 11.5)

0.002

Other complications

 Readmission for valve dysfunction (%, 95 % CI)

0.2(0.1 – 0.4)

0

0.2(0.1 – 0.4)

0.205

 Acute kidney injury (%, 95 % CI)

6.3(5.9 – 6.7)

6.3(5.1 – 7.7)

6.3(5.9 – 6.7)

0.971

 New AF (% without prior AF, 95 % CI)

34.2(33.4 – 35.1)

33.3(30.1 – 36.6)

34.3(33.5 – 35.1)

0.564

 Stroke/ TIA (%, 95 % CI)

2.4(2.2 – 2.6)

1.6(1.0 – 2.4)

2.5(2.2 – 2.7)

0.044

 Deep sternal wound infection (%, 95 % CI)

0.9(0.8 – 1.1)

1.2(0.7 – 1.0)

0.9(0.8 – 1.1)

0.247

 Anticoagulant complication (bleeding or embolization) (%, 95 % CI)

1.7(1.5 – 1.9)

2.8(2.0 – 3.7)

1.6(1.4 – 1.8)

0.002

 Heart failure (%, 95 % CI)

1.9(1.5 – 2.2)

2.4(1.4 – 3.9)

1.8(1.5 – 2.1)

0.274

 Septicaemia (positive blood culture with signs of infection)(%, 95 % CI)

1.6(1.4 – 1.8)

0.4(0.8 – 2.1)

0.6(1.4 – 1.8)

0.476